arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Microbot Medical Inc.

MBOT
$1.31 ▼ -0.07 (-5.40%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
68 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
40
Health
Weak
Neutral
auto_awesome

Analytical Summary

Microbot Medical Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $88.0M
Dividend Yield —
Revenue Growth None
Op. Margin —
ROIC -7.1% ↘
FCF / Share $-0.08 →
Trailing P/E —
Price / Book 1.3x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$241.00K
↑ +129.5% —
Net Income Profit after all expenses
$-3.67M
↓ -41.1% —
FCF / Share Free cash flow per share
$-0.08
↑ +0.6% —
Long-Term Debt Long-term obligations
$17.50K
↓ -75.4% —

Health Breakdown

Returns ↑
29
Cash Quality ↑
65

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters